fluconazole has been researched along with tacrolimus in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (11.48) | 18.2507 |
2000's | 26 (42.62) | 29.6817 |
2010's | 18 (29.51) | 24.3611 |
2020's | 10 (16.39) | 2.80 |
Authors | Studies |
---|---|
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Berdicevsky, I; Eads, E; Heitman, J; Horwitz, BA; Kaufman, G; Onyewu, C; Perfect, JR; Schell, WA; Ullmann, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Adibzadeh, M; Friccius, H; Pawelec, G; Pohla, H; Schenk, A; Siegels-Hübenthal, P | 1 |
Gonzalez-Pinto, I; Jain, A; Kusne, S; Mañez, R; Martin, M; Raman, D; Silverman, D; Starzl, TE; Warty, V | 1 |
Dix, SP; Geller, RB; Lin, LS; Mullins, RE; Osowski, CL; Wingard, JR | 1 |
Dhawan, A; Gonde, CE; Heaton, NJ; Mowat, AP; North-Lewis, PJ; Tredger, JM | 1 |
Bartlett, ST; Burke, GW; Gruessner, RW; Stock, PG | 1 |
Hossain, MA; Kohno, S; Maesaki, S; Marichal, P; Sanglard, D; Vanden Bossche, H | 1 |
Hairhara, Y; Hashizume, K; Hirata, M; Ijichi, M; Ito, M; Kawarasaki, H; Kita, Y; Kubota, K; Kusaka, K; Makuuchi, M; Matsukura, A; Nakatsuka, T; Saiura, A; Sano, K; Takayama, T; Tanaka, H; Watanabe, M; Yoshino, H | 1 |
Cardenas, ME; Cruz, MC; Del Poeta, M; Heitman, J; Perfect, JR | 1 |
Asano, Y; Gondo, H; Okamura, C; Okamura, T; Osaki, K; Shimoda, K | 1 |
Adamson, R; DiRenzo, T; Friedman, GS; Kaplan, B; Mathis, AS | 1 |
Asaka, M; Chiba, K; Hashino, S; Izumiyama, K; Suzuki, S; Takahata, M | 1 |
Blankenship, JR; Cardenas, ME; Cruz, MC; Davis, D; Del Poeta, M; Goldstein, AL; Heitman, J; McCusker, JH; Perfect, JR | 1 |
Ishida, H; Ito, S; Shinmura, H; Tanabe, K; Toda, F; Tokumoto, T; Toma, H | 1 |
Alvarez Grande, J; de Oña, M; Fresno, MF; Gómez, E; Herreros, M; Melón, S; Navascués, R; Tricas, L | 1 |
Bhaloo, S; Prasad, GV | 1 |
Boyle, GJ; Gandhi, S; Kurland, G; Law, YM; Mahnke, CB; Michaels, M; Miller, SA; Pigula, FA; Sutton, RM; Venkataramanan, R; Webber, SA | 1 |
Cox, GM; Ganous, TM; Kingsbury, JM; McCusker, JH; Pascon, RC | 1 |
Heitman, J; Onyewu, C; Perfect, JR; Wormley, FL | 1 |
Akhlaghi, F; Gleeson, M; McCaughan, G; McLachlan, AJ; Nelson, A; Zahir, H | 1 |
Heitman, J; Husain, S; Ison, M; Pruett, TL; Reedy, JL; Singh, N | 1 |
Cappello, D; Di Mare, M; Fiamingo, P; Gagliano, M; Giuffrida, G; Macarone, M; Severino, V; Sorbello, M; Spataro, M; Veroux, M; Veroux, P; Vizcarra, D | 1 |
Bunnachak, D; Jittikanont, S; Kanchanarattanakorn, K; Lumlertgul, D; Manoyot, A; Noppakun, K; Ophascharoensuk, V; Rojanasthien, N | 1 |
Fukuoka, N; Houchi, H; Ishida, T; Kawazoe, H; Ohnishi, H; Takiguchi, Y; Tanaka, H | 1 |
Aisa, Y; Ikeda, Y; Iketani, O; Mihara, A; Mori, T; Okamoto, S; Tanigawara, Y; Yamazaki, R | 1 |
Andes, D; Heitman, J; Nett, J; Uppuluri, P | 1 |
Abidi, MH; Ayash, LJ; Cadotte, C; Cronin, SM; Edwards, DJ; Ibrahim, RB; Jacobson, PA; Mulawa, J; Smith, DW; Uberti, JP | 1 |
de Jonge, H; Kuypers, DR; Naesens, M; Vanrenterghem, Y | 1 |
Costa-de-Oliveira, S; Dias, AS; Guerra, J; Pina-Vaz, C; Ricardo, E; Rodrigues, AG | 1 |
Blair, JE; Kokseng, SL | 1 |
Bunin, N; Goyal, RK; Grupp, SA; Han, K; Mada, SR; Pulsipher, MA; Venkataramanan, R; Wall, DA | 1 |
Chen, X; Chen, Z; Guan, W; Guo, X; Li, J; Li, Y; Mao, X; Wang, W | 1 |
Chen, Z; Li, H; Shi, W; Sun, S; Zhang, C | 1 |
Faria-Ramos, I; Miranda, IM; Pina-Vaz, C; Ricardo, E; Rodrigues, AG; Silva, RM | 1 |
Fung, HC; Peksa, GD; Schultz, K | 1 |
Cao, C; Li, X; Liang, H; Mo, D; Sun, C; Wei, L | 1 |
Baudet, H; Chardot, C; Debray, D; Elens, L; Girard, M; Guy-Viterbo, V; Haufroid, V; Lacaille, F; Musuamba, F; Reding, R; Wallemacq, P | 1 |
Chen, Z; Gao, Y; Li, H; Sun, S; Zhang, C; Zhang, X | 1 |
Jia, W; Li, C; Li, G; Liu, X; Wei, J; Zhang, H | 1 |
Matsuda, S; Nakagita, K; Oita, A; Takada, M; Terada, Y; Terakawa, N; Wada, K | 1 |
Averette, AF; Bahn, YS; Beom, JY; Cheong, E; Heitman, J; Hwangbo, A; Jung, JA; Kang, SH; Lee, KT; Lee, SJ; Lee, Y; Song, MC; Yoo, YJ; Yoon, YJ | 1 |
Chen, X; He, J; Liu, H; Liu, Y; Ma, J; Yang, W; Yin, C; Yu, Y; Zhong, L; Zou, H | 1 |
Hedvat, J; Lange, NW; Salerno, DM; Tsapepas, DS | 1 |
Cheng, S; Du, J; Tang, M; Yin, T | 1 |
Kaur, R; Kumar, K; Moirangthem, R | 1 |
Asch, WS; Casal, GH; Cohen, EA; Johnston, JP; Reardon, DP | 1 |
Bubalo, JS; Gu, TM; Le, H; Lewis, JS | 1 |
Aoki, J; Fukuda, T; Furukawa, T; Hashimoto, H; Inamoto, Y; Ito, A; Kim, SW; Nakashima, T; Tanaka, T | 1 |
Alghamdi, A; Darland, L; Hooper, DK; Lazear, D; Mizuno, T; Ramsey, LB; Seay, S; Varnell, CD | 1 |
Abdorahimi, M; Ahmadikia, K; Badali, H; Gharehbolagh, SA; Khodavaisy, S; Mahmoudi, S; Meis, JF; Rezaie, S | 1 |
Hirai, T; Ino, K; Ishibashi, M; Iwamoto, T; Shinogi, Y; Tawara, I | 1 |
3 review(s) available for fluconazole and tacrolimus
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinically significant drug-drug interaction between tacrolimus and fluconazole in stable renal transplant recipient and literature review.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Transplantation; Tacrolimus | 2020 |
3 trial(s) available for fluconazole and tacrolimus
Article | Year |
---|---|
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.
Topics: Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Fluconazole; Graft Rejection; Humans; Immunosuppressive Agents; Prospective Studies; Tacrolimus; Transplantation, Homologous | 1996 |
Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Algorithms; Diltiazem; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Prednisolone; Retrospective Studies; Tacrolimus | 2005 |
Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
Topics: Adult; Antifungal Agents; Area Under Curve; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Period; Tacrolimus | 2006 |
55 other study(ies) available for fluconazole and tacrolimus
Article | Year |
---|---|
Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model.
Topics: Antifungal Agents; Calcineurin; Colony Count, Microbial; Culture Media; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Ergosterol; Fluconazole; Humans; Immunosuppressive Agents; Naphthalenes; Signal Transduction; Skin; Tacrolimus; Terbinafine; Tinea; Trichophyton | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells.
Topics: Antifungal Agents; Cells, Cultured; Cyclosporine; Cytokines; Fluconazole; Gene Expression; Humans; Itraconazole; Ketoconazole; Lymphocytes; Miconazole; Tacrolimus | 1992 |
Fluconazole therapy in transplant recipients receiving FK506.
Topics: Drug Interactions; Fluconazole; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Tacrolimus | 1994 |
Tacrolimus (FK506) malabsorption: management with fluconazole coadministration.
Topics: Absorption; Child; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Tacrolimus | 1997 |
Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation.
Topics: Administration, Oral; Antifungal Agents; Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Fluconazole; Graft Rejection; Guidelines as Topic; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Mycoses; Pancreas Transplantation; Tacrolimus; United States; Virus Diseases | 1998 |
Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genes, MDR; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Tacrolimus | 1998 |
Effect of fluconazole on blood levels of tacrolimus.
Topics: Adolescent; Adult; Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Living Donors; Male; Middle Aged; Tacrolimus | 1999 |
Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans.
Topics: Anti-Bacterial Agents; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Caspofungin; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Echinocandins; Fluconazole; Humans; Immunophilins; Lipopeptides; Macrolides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Tacrolimus; Tacrolimus Binding Proteins | 2000 |
Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and fluconazole therapy following allogeneic bone marrow transplantation.
Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Drug Interactions; Female; Fluconazole; Humans; Immunosuppressive Agents; Pelger-Huet Anomaly; Tacrolimus | 2000 |
Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors.
Topics: Adult; Antifungal Agents; Black or African American; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Ethnicity; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Retrospective Studies; Sex Factors; Tacrolimus; United States | 2001 |
Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus.
Topics: Adult; Anemia, Aplastic; Anticonvulsants; Blood-Brain Barrier; Bone Marrow Transplantation; Brain Diseases; Brain Edema; Ceftazidime; Cerebral Hemorrhage; Cyclosporine; Diagnosis, Differential; Diuretics; Endothelium, Vascular; Epilepsy, Generalized; Female; Fluconazole; Graft vs Host Disease; Headache; Humans; Immunosuppressive Agents; Intracranial Hypertension; Magnetic Resonance Imaging; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Calcineurin is essential for survival during membrane stress in Candida albicans.
Topics: Antifungal Agents; Base Sequence; Blotting, Northern; Calcineurin; Candida albicans; Cyclosporine; DNA Primers; Drug Resistance, Microbial; Fluconazole; Gene Expression Regulation, Fungal; Genes, Fungal; Methyltransferases; Tacrolimus | 2002 |
Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients.
Topics: ABO Blood-Group System; Adult; Antifungal Agents; Area Under Curve; Blood Group Incompatibility; Body Weight; Drug Interactions; Female; Fluconazole; Histocompatibility Testing; HLA-DR Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Retrospective Studies; Tacrolimus; Transplantation, Homologous | 2002 |
[Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime].
Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Epstein-Barr Virus Infections; Fluconazole; Ganciclovir; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppression Therapy; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Postoperative Complications; Tacrolimus | 2002 |
Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report.
Topics: Adult; Clarithromycin; Creatinine; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Rifampin; Tacrolimus | 2003 |
Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation.
Topics: Analysis of Variance; Antifungal Agents; Child; Female; Fluconazole; Humans; Immunosuppressive Agents; Itraconazole; Male; Mycoses; Organ Transplantation; Retrospective Studies; Tacrolimus | 2003 |
Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adaptation, Physiological; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Fluconazole; Gene Deletion; Gene Expression Regulation, Fungal; Genes, Fungal; Homocysteine; Hot Temperature; Melanins; Methionine; Mice; Microbial Sensitivity Tests; Mutation; RNA, Fungal; RNA, Messenger; Tacrolimus; Transcription, Genetic; Virulence; Virulence Factors | 2004 |
The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans.
Topics: Animals; Antifungal Agents; Calcineurin; Candida albicans; Drug Resistance, Fungal; Fluconazole; Mice; Mice, Inbred ICR; Tacrolimus | 2004 |
Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients.
Topics: Calcineurin Inhibitors; Calcium; Candida albicans; Drug Resistance, Fungal; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Serum; Tacrolimus | 2006 |
Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Caspofungin; Cyclosporine; Echinocandins; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lipopeptides; Middle Aged; Peptides, Cyclic; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 2006 |
Change of the blood concentration of tacrolimus after the switch from fluconazole to voriconazole in patients receiving allogeneic hematopoietic stem cell transplantation.
Topics: Fluconazole; Humans; Immunosuppressive Agents; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Tacrolimus; Triazoles; Voriconazole | 2006 |
Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole.
Topics: Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Retrospective Studies; Tacrolimus | 2008 |
Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms.
Topics: Animals; Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida albicans; Cyclosporine; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Humans; Microbial Sensitivity Tests; Rats; Tacrolimus | 2008 |
Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antiemetics; Antifungal Agents; Aprepitant; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Injections, Intravenous; Liver Function Tests; Male; Middle Aged; Morpholines; Mycoses; Retrospective Studies; Tacrolimus; Young Adult | 2008 |
Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Drug Interactions; Female; Fluconazole; Genotype; Humans; Kidney Transplantation; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Tacrolimus | 2008 |
Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Enzyme Inhibitors; Fluconazole; Fungal Proteins; Gene Expression Profiling; Humans; Ibuprofen; Membrane Transport Proteins; Microbial Sensitivity Tests; Tacrolimus | 2009 |
Successful kidney transplantation after coccidioidal meningitis.
Topics: Adult; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Humans; Immunosuppressive Agents; Kidney Transplantation; Meningitis, Fungal; Tacrolimus; Transplantation Immunology; Treatment Outcome | 2011 |
Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.
Topics: Adolescent; Antifungal Agents; Area Under Curve; Bone Marrow Transplantation; Child; Child, Preschool; Drug Monitoring; Female; Fluconazole; Graft vs Host Disease; Half-Life; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Myeloablative Agonists; Sirolimus; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2013 |
Mutations adjacent to the end of transmembrane helices 6 and 7 independently affect drug efflux capacity of yeast ABC transporter Pdr5p.
Topics: Antifungal Agents; Antineoplastic Agents; ATP-Binding Cassette Transporters; Biological Transport; Cell Membrane; Cycloheximide; Drug Resistance, Fungal; Fluconazole; Immunosuppressive Agents; Mutagenesis, Site-Directed; Mutation; Rhodamines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Tacrolimus | 2014 |
A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC)--combining tacrolimus with FLC.
Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Tacrolimus; Time Factors | 2014 |
In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; ATP-Binding Cassette Transporters; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression; Humans; Male; Mutation; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sterol 14-Demethylase; Tacrolimus; Voriconazole | 2014 |
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2015 |
In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.
Topics: Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Synergism; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Penicillium; Tacrolimus; Yeasts | 2014 |
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.
Topics: Adolescent; Child; Child, Preschool; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP3A; Female; Fluconazole; Genotype; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Transplantation; Male; Metabolic Clearance Rate; Retrospective Studies; Tacrolimus; Tissue Donors; Transplant Recipients | 2014 |
Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata.
Topics: Antifungal Agents; Biological Transport; Candida glabrata; Drug Resistance, Fungal; Drug Synergism; Flow Cytometry; Fluconazole; Fungal Proteins; Gene Expression Profiling; Humans; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Fungal; Tacrolimus | 2015 |
The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida albicans; Candidiasis; Cyclosporine; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Humans; Microbial Sensitivity Tests; Tacrolimus | 2016 |
Effect of fluconazole on the pharmacokinetics of everolimus and tacrolimus in a heart transplant recipient: Case report.
Topics: Antifungal Agents; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Everolimus; Fluconazole; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Polymorphism, Single Nucleotide; Tacrolimus | 2018 |
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin; Calcineurin Inhibitors; Candida albicans; Candidiasis; Cells, Cultured; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Immunosuppressive Agents; Male; Mice; Microbial Sensitivity Tests; Tacrolimus; Tacrolimus Binding Protein 1A | 2018 |
Managing the significant interaction between XR tacrolimus and fluconazole in kidney transplant recipients.
Topics: Fluconazole; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Tacrolimus; Transplant Recipients | 2020 |
Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients.
Topics: Antifungal Agents; Drug Interactions; Fluconazole; Humans; Kidney Transplantation; Retrospective Studies; Tacrolimus; Voriconazole | 2022 |
Two Functionally Redundant FK506-Binding Proteins Regulate Multidrug Resistance Gene Expression and Govern Azole Antifungal Resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida glabrata; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genes, MDR; Humans; Tacrolimus; Tacrolimus Binding Proteins | 2021 |
Impact of Low-Dose Fluconazole on Tacrolimus Dosing in Renal Transplant.
Topics: Antifungal Agents; Azoles; Drug-Related Side Effects and Adverse Reactions; Fluconazole; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Nystatin; Retrospective Studies; Tacrolimus | 2022 |
Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
Topics: Antifungal Agents; Cyclosporine; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Nitriles; Pyridines; Retrospective Studies; Tacrolimus; Triazoles | 2022 |
Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal.
Topics: Acetates; Antifungal Agents; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Quinazolines; Tacrolimus; Voriconazole | 2022 |
Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients.
Topics: Child; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Fluconazole; Genotype; Humans; Immunosuppressive Agents; Kidney Transplantation; Polymorphism, Single Nucleotide; Tacrolimus | 2023 |
In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris.
Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida auris; Candida glabrata; Candida parapsilosis; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Tacrolimus | 2023 |
Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis.
Topics: Adult; Antifungal Agents; Azoles; Drug Interactions; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Retrospective Studies; Tacrolimus | 2023 |